Vimarsana
Biggest News Aggregation in the World

Page 20 - Na Sequencing News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Na Sequencing. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Na Sequencing Today - Breaking & Trending Today

Understanding Pregnancy Complications - Vimarsana News

Understanding Pregnancy Complications

In this interview, Dr. Stephen Lye, the Interim Director of the Lunenfeld-Tanenbaum Research Institute at Sinai Health, talks to NewsMedical about how AI and DNA sequencing can be used for understanding pregnancy complications.

Reconstructing ancient bacterial genomes can revive previously unknown molecules – offering a potential source for new antibiotics - Vimarsana News

Reconstructing ancient bacterial genomes can revive previously unknown molecules – offering a potential source for new antibiotics

Ancient microbes likely produced natural products their descendants today do not. Tapping into this lost chemical diversity could offer a potential source of new drugs.

Asia-Pacific and Middle East NGS Global Market to 2027: - Vimarsana News

Asia-Pacific and Middle East NGS Global Market to 2027:

Dublin, April 27, 2023 (GLOBE NEWSWIRE) -- The "Asia-Pacific and Middle East NGS Market: Focus on Offering, Platform, Throughput, Technology Type,...

Tecan and Oxford Nanopore build new alliance - Vimarsana News

Tecan and Oxford Nanopore build new alliance

Collaboration aims to build automated nanopore sequencing library preparation for any-length fragments of native DNA/RNA

New computational method identifies routes of cellular differentiation in acute myeloid leukemia - Vimarsana News

New computational method identifies routes of cellular differentiation in acute myeloid leukemia

Researchers have developed a new method to distinguish between cancerous and healthy stem cells and progenitor cells from samples of patients with acute myeloid leukemia (AML), a disease driven by malignant blood stem cells that have historically been difficult to identify.